BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3817597)

  • 1. [Treatment of disorders of the climacteric by vaginal, rectal and transdermal estrogen substitution].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):248-53. PubMed ID: 3817597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone substitution by injectable preparations and skin implants].
    Kuhl H
    Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen replacement therapy: an overview.
    Brenner PF
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):7-14. PubMed ID: 2906341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral hormone therapy in the pre- and postmenopausal period].
    Braendle W; Bettendorf G
    Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transdermal estrogen substitution in the postmenopause].
    Fontana-Klaiber H; Koller J; Keller PJ
    Gynakol Rundsch; 1987; 27(4):225-33. PubMed ID: 3436573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen treatment of women in their climacteric].
    Fock D
    Katilolehti; 1978 Apr; 83(4):144-6. PubMed ID: 247035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].
    Schenkel L; von Graffenried A
    Schweiz Rundsch Med Prax; 1987 Mar; 76(14):358-61. PubMed ID: 3589291
    [No Abstract]   [Full Text] [Related]  

  • 11. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users?
    Bielanski TE
    J Fam Pract; 2001 Oct; 50(10):838. PubMed ID: 11674879
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost-benefit-risk analysis of estrogen treatment in the climacteric].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):266-75. PubMed ID: 3102324
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pro and contra hormonal substitution in the climacteric].
    Vesper B
    Gynakol Rundsch; 1988; 28 Suppl 2():175-8. PubMed ID: 3234914
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and treatment of mental disorders in women during the climacteric period].
    Tiushina NA; Balabanova VV; Balan VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):79-82. PubMed ID: 1664621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen replacement therapy on cardiovascular disease: literature review.
    Lehman KD; Calkins JW
    Kans Med; 1988 Nov; 89(11):308-13. PubMed ID: 3060652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transdermal estrogen substitution in the climacteric syndrome].
    Melchert F; Schenkel L; Asche H
    Med Monatsschr Pharm; 1988 Jan; 11(2):88-90. PubMed ID: 3357481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
    Lauritzen C; Teucher T; Schmitz H
    Arzneimittelforschung; 1995 Mar; 45(3):315-22. PubMed ID: 7741793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
    van Leusden HA
    Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 20. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.